| abstract |
This invention relates to the oncofetal p65 protein, having the Entrez Protein Accession Number CAA05410.2 in the NCBI database, herein identified as containing a Nuclear Hormone Receptor Ligand Binding Domain, to functional equivalents of this protein such as the TdT binding protein (Entrez Protein Accession Number BAB62888.1) and to the use of this protein, its functional equivalents and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease. |